HEATHER EVANS: Open Payments
NPI 1558106492 · WOOSTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,202 in 45 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $326 · 2025 $1,202
Food & beverage: $1,202
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $464 |
| Janssen Biotech, Inc. | 3 | $233 |
| Madrigal Pharmaceuticals | 1 | $143 |
| Gilead Sciences, Inc. | 1 | $104 |
| Lilly USA, LLC | 4 | $80 |
| Phathom Pharmaceuticals, Inc. | 3 | $57 |
| Aimmune Therapeutics, Inc. | 2 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Ardelyx, Inc. | 1 | $24 |
| Braintree Laboratories, Inc. | 1 | $15 |
Products named: TREMFYA, RINVOQ, SKYRIZI, REZDIFFRA, Livdelzi, OMVOH, LINZESS, VOQUEZNA.
Industry payments across OH — which companies pay providers there.
